ASTRAZENECA PHARMA INDIA LIMITED

Business Segments AstraZeneca Pharma India Limited

Equities

ASTRAZEN

INE203A01020

Pharmaceuticals

Delayed Bombay S.E. Other stock markets 02:18:43 09/03/2026 pm IST			5-day change	1st Jan Change
8,545.45 ^INR	-2.23%		-2.87%	-5.16%

11/02	AstraZeneca Pharma India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
11/02	AstraZeneca Pharma India Dec-quarter PAT 325.9 million rupees	RE

Sales 2025 by Business Segment

© MarketScreener.com See more

Sales 2025 by Geography

© MarketScreener.com See more

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Breakdown by Business Segment (INR)

Fiscal Period: March	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Pharmaceutical Products
Healthcare						813.56Cr	805.6Cr	1TCr	1.3TCr	1.72TCr
Total Assets						774.71Cr	856.56Cr	984.87Cr	1.08TCr	1.52TCr
Interest Expense						-1.09Cr	-95L	-63L	-1.2Cr	-1.46Cr
Income Tax Expense						34Cr	21Cr	35Cr	58Cr	41Cr
CAPEX						-7.71Cr	-9.62Cr	-8.52Cr	-11Cr	-1.75Cr
EBT						127.09Cr	83Cr	134.1Cr	219.54Cr	156.36Cr
D&A						20Cr	17Cr	16Cr	15Cr	39Cr
Operating Income						-	-	-	-	-
Net Income						93Cr	62Cr	99Cr	161.51Cr	115.74Cr
Total Assets						-	-	-	-	-
Total Assets						-	-	-	-	-
Life Sciences Tools and Services
Others						-	-	-	-	-
Total Assets						-	-	-	-	-
Operating Income						-	-	-	-	-

Geographical Revenue Distribution History

Geographical breakdown of sales (INR)

Fiscal Period: March	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
India						779.39Cr	759.17Cr	938.92Cr	1.2TCr	1.61TCr
Total Assets						74Cr	69Cr	64Cr	61Cr	28Cr
CAPEX						-	-	-	-	-
Outside India						34Cr	46Cr	64Cr	94Cr	109.69Cr
Total Assets						-	-	-	-	-

Stock Market
Equities
ASTRAZEN Stock
Financials AstraZeneca Pharma India Limited
Business Segments

SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!

BENEFIT NOW